학술논문
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial
Document Type
Article
Author
Source
In Annals of Oncology February 2014 25(2):429-434
Subject
Language
ISSN
0923-7534